Dow Up 0.87% Nasdaq Up 1.24%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
22.00 Down 12.21(35.69%) 9:45AM EDT - Nasdaq Real Time Price
Prev Close:34.21
Open:22.86
Bid:22.75 x 100
Ask:22.88 x 200
1y Target Est:60.60
Beta:-0.22
Next Earnings Date:N/A
Day's Range:21.51 - 23.00
52wk Range:21.51 - 85.34
Volume:3,107,630
Avg Vol (3m):1,035,610
Market Cap:650.00M
P/E (ttm):N/A
EPS (ttm):-1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGRDown 35.69%650.00M
AZNUp 0.11%91.79B
MRKUp 1.17%167.25B
PFEUp 1.08%191.26B

Key Statistics

Forward P/E (1 yr):14.26
P/S (ttm):9.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.87
Quarterly EPS Est (Dec-14) :0.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback